Bluebird Bio's IPO

Bluebird Bio raised a round of funding on June 19, 2013. Investors include Public.

Bluebird Bio, formerly Genetix Pharmaceuticals, is developing gene therapies for severe genetic disorders. At the heart of bluebird bio's product creation efforts is its broadly applicable gene therap…

Articles about Bluebird Bio's IPO: